AMT
55
-3
EXPE
77
3
WYNN
36
2
NTRS
54
7
IVZ
53
5
CF
60
3
AZO
43
-2
AON
56
-4
BAX
33
-2
WM
65
3
PNR
75
3
PNC
59
4
CTAS
58
2
FITB
60
2
GRMN
52
2
VRSK
38
3
MAT
54
3
NI
63
-4
NDAQ
63
4
SLB
56
6
AMT
55
-3
EXPE
77
3
WYNN
36
2
NTRS
54
7
IVZ
53
5
CF
60
3
AZO
43
-2
AON
56
-4
BAX
33
-2
WM
65
3
PNR
75
3
PNC
59
4
CTAS
58
2
FITB
60
2
GRMN
52
2
VRSK
38
3
MAT
54
3
NI
63
-4
NDAQ
63
4
SLB
56
6
Financhill
Back

Biotricity 10K Form

Sell
18

BTCY
Biotricity

Last Price:
0.32
Seasonality Move:
-17.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-14 10Q BTCY/Biotricity Quarterly
2020-07-15 10K BTCY/Biotricity Annual
2020-02-14 10Q BTCY/Biotricity Quarterly
2019-11-14 10Q BTCY/Biotricity Quarterly
2019-08-15 10Q BTCY/Biotricity Quarterly
2019-07-16 10K BTCY/Biotricity Annual

Receive BTCY News And Ratings

See the #1 stock for the next 7 days that we like better than BTCY

BTCY Financial Statistics

Sales & Book Value

Annual Sales: $12.06M
Cash Flow: $-1.49M
Price / Cash Flow: 0
Annual Sales: $-1.38
Price / Book: 0

Profitability

EPS (TTM): -1.73900
Net Income (TTM): $-14.38M
Gross Margin: $8.36M
Return on Equity: 0%
Return on Assets: -241.07%

Biotricity Earnings Forecast

Key Biotricity Financial Ratios

  • The Gross Profit Margin over the past 11 years for BTCY is 69.27%.
  • The Selling, General & Administrative Expenses for BTCY have been equal to 121.13% of Gross Profit Margin.
  • The Research & Development expenses have been 21.32% of Revenue.
  • The Interest Expense is -36.84% of Operating Income.
  • The Net Earning history of BTCY is -116.84% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Biotricity Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Technology
Sector: Health Care
Current Symbol: BTCY
Website: biotricity.com

Debt

Debt-to-Equity Ratio: -0.79
Current Ratio: 0.2
Quick Ratio: 0.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BTCY Technical Analysis vs Fundamental Analysis

Sell
18
Biotricity (BTCY) is a Sell

Is Biotricity a Buy or a Sell?

  • Biotricity stock is rated a Sell
    The current Biotricity [BTCY] share price is $0.30. The Score for BTCY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.